Project Details
Description
Preparation and implementation of a clinical trial endTB-Q which relates to testing novel regimes to treat MDR-TB resistant to fluoroquinilones
Description
Preparation and implementation of a clinical trial endTB-Q which relates to testing novel regimes to treat MDR-TB resistant to fluoroquinilones
Acronym | EndTB O5 |
---|---|
Status | Active |
Effective start/end date | 1/07/20 → 30/06/25 |
Funding
- MSF France: €969,047.49